Abstract
The surgeon’s first responsibility in the management of carcinoma of the prostate is to detect the presence of the disease. Malignancy may be suspected on digital palpation of the prostate, and then microscopic evidence must be provided by biopsy. Alternatively, the carcinoma may be discovered incidentally in tissue removed for the correction of bladder-neck obstruction. Whichever way the tumour is diagnosed, it is the surgeon’s next responsibility to define the stage of the disease — the local extent of the primary growth, whether it is necessary to study the pelvic lymph nodes, and whether there is any evidence of distant metastases. More difficult, an attempt should be made to gauge the malignant potential of the tumour in a particular patient. Once this information is assembled, the surgeon has to choose the best therapeutic approach. He can try to cut out the cancer: but few of us believe that this is a valid first-line approach, especially with prostate carcinoma. If the patient is fortunate he may be entered into a well-thought-out, carefully constructed prospective trial. This will ensure that his disease is adequately staged, and management will be by one of two or more options which are appropriate for his disease at his age. In may be pointed out that there is evidence that patients in trials do better than those who are not (Lennox et al. 1979). The surgeon’s contribution to the endocrine management of the patient may include orchidectomy and, later in the course of the disease, adrenalectomy or pituitary ablation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnes RW, Ninan CA (1972) Carcinoma of the prostate: biopsy and conservative therapy. J Urol 108: 897–900
Barzell W, Bean MA, Hilaris BS, Whitmore WF (1977) Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol 118: 278–282
Bauer WC, McGarvan MH, Carlin MR (1960) Unsuspected carcinoma of the prostate in suprapubic prostatectomy specimens. Cancer 13: 370–378
Berlin BB, Cornwell PM, Connelly RR, Eisenberg H (1968) Radical perineal prostatectomy for carcinoma of the prostate: survival in 143 cases treated from 1935–1958. J Urol 99: 97–101
Birke G, Franksson C, Plantin LO (1955) Steroid response to hormone therapy in prostatic cancer. Acta Chir Scand 109: 129–149
Blackard CE, Mellinger GT, Gleason DF (1971) Treatment of stage 1 carcinoma of the prostate: a preliminary report. J Urol 106: 729–733
Chilton CP, Morgan RJ, England HR, Paris AMI, Blandy JP (1978) A critical evaluation of the results of transurethral resection of the prostate. Br J Urol 50: 542–546
Clark P, Houghton L (1977) Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 49: 419–425
Culp OS, Meyer JJ (1973) Radical prostatectomy in the treatment of prostatic cancer. Cancer 32: 1113–1118
Daves JA, Tomskey GC, Cohen AE (1961) Transrectal needle biopsy of the prostate. J Urol 85: 180–182
Denton SE, Valk WL, Jacobson JM, Kettunen RC (1967) Comparison of the perineal needle biopsy and the transurethral prostatectomy in the diagnosis of prostatic carcinoma: an analysis of 300 cases. J Urol 97: 127–129
Emmett JL, Greene LF, Papantoniou A (1960) Endocrine therapy in carcinoma of the prostate gland: 10 year survival studies. J Urol 83: 471–484
Fergusson JD, Hendry WF (1971) Pituitary irradiation in advanced carcinoma of the prostate: analysis of 100 cases. Br J Urol 43: 514–519
Franzén S, Giertz G, Zajicek J (1960) Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 32: 193–196
Freiha FS, Pistenma DA, Bagshaw MA (1979) Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary? J Urol 122: 176–177
Golimbu M, Morales P (1979) Stage A2 prostatic carcinoma — should the staging system be reclassified? Urology 13: 592–596
Golimbu M, Morales P (1980) Extended pelvic lymphadenectomy. Urology 15: 298–301
Golimbu M, Morales P, Al-Askari S, Brown J (1979) Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121: 617–620
Hendry WF (1974) Adrenalectomy and hypophysectomy in disseminated prostatic cancer. In: Castro JE (ed) The treatment of prostatic hypertrophy and neoplasia. Medical and Technical Publishing, Lancaster, pp 171–196
Hendry WF, Williams JP (1971) Transrectal prostatic biopsy. Br Med J 4: 595–597
Jewett HJ, Eggleston JC, Yawn DH (1972) Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol 107: 1034–1040
Lennox EL, Stiller CA, Morris Jones PH, Kinnier Wilson LM (1979) Nephroblastoma: treatment during 1970–3 and the effect on survival of inclusion in the first MRC trial. Br Med J 2: 567–569
Loening SA, Schmidt JD, Brown RC, Hawtrey CE, Fallon B, Culp DA (1977) A comparison between lymphangiography and pelvic node dissection in the staging of prostatic cancer. J Urol 117: 752–756
Mahoney EM, Harrison JH (1972) Bilateral adrenalectomy for palliative treatment of prostatic cancer. J Urol 108: 936–938
Mellinger GT, Gleason DF, Bailar J III (1967) The histology and prognosis of prostatic cancer. J Urol 97: 331–337
Miller GM, Himan F (1954) Cortisone treatment in advanced carcinoma of the prostate. J Urol 72: 485–496
Murphy GP, Reynoso G, Schoonees R, Gailani S, Bourke R, Kenny GM, Mirand EA, Schalch DS (1971) Hypophysectomy and adrenalectomy for disseminated prostatic carcinoma. J Urol 105: 817–825
Nesbit RM, Baum WC (1950) Endocrine control of prostatic carcinoma: clinical and statistical survey of 1818 cases. JAMA 143: 1317–1320
O’Donoghue EPN, Pugh RCB (1977) Early diagnosis of prostatic carcinoma: the role of transurethral resection. Br J Urol 49: 705–710
O’Donoghue EPN, Shridhar P, Sherwood T, Williams JP, Chisholm GD (1976) Lymphography and pelvic lymphadenectomy in carcinoma of the prostate. Br J Urol 48: 689–696
Paulson DF, Uro-Oncology Research Group (1979) The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121:300–302
Peeling WB, Griffiths GJ, Evans RT, Roberts EE (1979) Diagnosis and staging of prostatic cancer by transrectal ultrasonography. A preliminary study. Br J Urol 51: 565–569
Purser BN, Robinson BC, Mostofi FK (1967) Comparison of needle biopsy and transurethral resection biopsy in the diagnosis of carcinoma of the prostate. J Urol 98: 224–228
Robinson MRG, Shearer RJ, Fergusson JD (1974) Adrenal suppression in the treatment of carcinoma of prostate. Br J Urol 46: 555–559
Shearer RJ, Hendry WF, Sommerville IF, Fergusson JD (1973) Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. Br J Urol 45: 668–677
UICC (1978) TNM Classification of Malignant Tumours, 3rd edn. UICC, Geneva
Veenema RJ, Gursel EO, Lattimer JK (1977) Radical retropubic prostatectomy for cancer: a 20-year experience. J Urol 117: 330–331
Veterans Administration Co-operative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg. Gynecol Obstet 124: 1011–1017
Vickery AL, Kerr WS (1963) Cancer of the prostate treated by radical prostatectomy: a clinicopathological survey of 187 cases followed for 5 years and 148 cases followed for 10 years. Cancer 16: 1598–1608
Whitmore WF, Batata M, Hilaris B (1979) Prostatic irradiation: Iodine-125 implantation. In: Johnson DE, Samuels ML (eds) Cancer of the genitourinary tract. Raven Press, New York, pp 195–205
Zingg EJ, Fuchs WA, Heritier P, Gothlin J (1974) Lymphography in carcinoma of the prostate. Br J Urol 46: 549–554
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hendry, W.F. (1981). Surgery. In: Duncan, W. (eds) Prostate Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 78. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81621-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-81621-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81623-9
Online ISBN: 978-3-642-81621-5
eBook Packages: Springer Book Archive